HMGB1 and cancer: In our large, well characterised cohort, we have identified an HMGB1 expression profile switch with dynamic subcellular localisation between normal and T1 malignancy, and a striking HMGB1 expression signature at the leading invasive edge in the majority of polyp cancer lesions.